10x Genomics(TXG) - 2022 Q3 - Quarterly Report

Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 45-5614458 (State or other jurisdiction of incorporation or organization) (Mark One) ☒ QUARTERLY REPOR ...